CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WYNANDS, J. E.
Right arrow Articles by BURFOOT, M. F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by WYNANDS, J. E.
Right arrow Articles by BURFOOT, M. F.

Canadian Journal of Anesthesia, Vol 12, 587-594, Copyright © 1965 by Canadian Anesthesiologists' Society

A Clinical Study of Propanidid (FBA 1420)

J. E. WYNANDS B.A., M.D., C.M.1 and M. F. BURFOOT M.A., B.M., B.CH.1

1 Department of Anaesthesia, Royal Victoria Hospital, Montreal

Propanidid, a non-barbiturate, ultra-short-acting anaesthetic agent has been under clinical trial and the results of its use in 525 cases are presented.

In general it was found to be a useful and safe drug. Following a single injection of 5 to 6 mg.//kg., patients fell asleep within thirty seconds and awoke in less than ten minutes. This rapid recovery necessitates prompt administration of further anaesthetic agents if surgery lasts longer than a few minutes. A satisfactory technique using Propanided as an induction agent to inhalational anaesthesia is described.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1965 by the Canadian Anesthesiologists' Society.